David Crispino Volpe, Chief Financial Officer at AdvanSource Biomaterials Corp (ASNB), bought 75,000 shares at $0.03 ($2K) on 2012-09-18, disclosed to the SEC on 2012-09-19.
Open-market purchase of $2k ASNB by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.02 | 50,000 | $1K | 55.6% |
| 2 | $0.03 | 20,000 | $600 | 33.3% |
| 3 | $0.04 | 5,000 | $200 | 11.1% |
| Total | $0.02 avg | 75,000 | $2K | 100% |
| Filing → |
| ASNB | BUY | 2012-12-10 | $300 | — | Filing → |
| ASNB | BUY | 2012-12-04 | $150 | — | Filing → |
| ASNB | BUY | 2012-12-03 | $200 | — | Filing → |